ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial.
Obstructive sleep apnoea (OSA), atrial fibrillation (AF) and sudden cardiac death (SCD) may occur concomitantly, and are of considerable epidemiological interest, potentially leading to morbidity and mortality. Effective treatment of OSA with continuous positive airway pressure (CPAP) could prevent...
主要な著者: | Schlatzer, C, Bratton, D, Craig, S, Kohler, M, Stradling, J |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
BMJ Publishing Group
2016
|
類似資料
-
Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
著者:: Craig, SE, 等
出版事項: (2012) -
Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial.
著者:: Craig, SE, 等
出版事項: (2012) -
Leukoaraiosis on MRI in patients with minimally symptomatic obstructive sleep apnoea.
著者:: Schulz, U, 等
出版事項: (2013) -
Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials.
著者:: Bratton, D, 等
出版事項: (2014) -
Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea.
著者:: Ayers, L, 等
出版事項: (2009)